Q2 2026 13F · SEC CIK 1358331

Bruce & Co., Inc.

Mutual fund managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $369.5M
Reported positions: 41
Top holdings a year, 3 yrs: +13.9%
Assets under management: $379.5M

Bruce & Co., Inc. is a mutual fund manager that reported 41 positions worth $369.5M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Abbvie Inc (ABBV, 8.2%), Allstate Corp (ALL, 7.9%), Aercap Holdings NV (AER, 7.3%). A portfolio copying its top holdings returned 13.9% a year over the last 3 years, against 20.4% for the S&P 500.

Bruce & Co., Inc. holdings all 41 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Bruce & Co., Inc. 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
ABBVAbbvie Inc	8.2%	7.6%	121,000	-1.2%	$30.4M
ALLAllstate Corp	7.9%	7.3%	122,500	-2.4%	$29.1M
AERAercap Holdings NV	7.3%	7.2%	185,000	+0.8%	$27.0M
NEENextera Energy	7.0%	8.0%	294,300	-2.0%	$25.8M
MRKMerck Co	6.6%	6.6%	190,800	-1.0%	$24.5M
UHALBU Haul Holding Company	6.5%	5.8%	417,000	-7.7%	$24.1M
DUKDuke Energy Corp New	5.0%	5.5%	144,816	-0.7%	$18.3M
VICRVicor Corp	4.9%	3.0%	48,000	-26.2%	$18.2M
XELXcel Energy Inc	4.0%	4.2%	182,500	-1.1%	$14.7M
CMSCMS Energy Corp	3.2%	3.5%	153,000	-1.9%	$11.7M
TAt&t Inc	2.9%	4.3%	518,000	-1.0%	$10.7M
AAPLApple Inc	2.9%	2.8%	36,900	-5.1%	$10.7M
BBNXBeta Bionics Inc	2.8%	1.6%	665,700	+20.9%	$10.4M
IIINInsteel Industries Inc	2.8%	3.3%	343,423	+0.0%	$10.4M
ABTAbbott Laboratories	2.8%	3.3%	112,300	-1.3%	$10.2M
NEMNewmont Corp	2.5%	3.1%	100,000	+0.0%	$9.3M
AVAAvista Corp	2.2%	2.3%	200,000	-0.7%	$8.2M
ADMArcher Daniels Midland Co	2.1%	2.1%	100,000	+0.0%	$7.6M
BGBunge Global SA	2.0%	2.5%	70,000	+0.0%	$7.5M
SUPNSupernus Pharmaceuticals	1.9%	1.5%	150,000	+50.0%	$7.0M
PFEPfizer Inc	1.7%	2.2%	268,200	-1.4%	$6.5M
DARDarling Ingredients Inc	1.6%	1.9%	105,000	-0.9%	$5.7M
KODKodiak Sciences Inc	1.5%	1.6%	145,000	+0.0%	$5.6M
CCChemours Co	1.4%	1.6%	250,000	+0.0%	$5.1M
UHALU Haul Holding Company	1.3%	1.0%	72,600	-1.8%	$4.8M
LYBLyondellbasell Industries NV	0.9%	1.4%	60,000	+0.0%	$3.2M
PSNLPersonalis Inc	0.8%	0.4%	233,000	+0.0%	$3.1M
FATEFate Therapeutics Inc	0.7%	0.3%	989,188	+25.3%	$2.7M
LLYEli Lilly & Co	0.6%	0.5%	2,000	+0.0%	$2.4M
RLIRli Corp	0.6%	0.7%	40,000	-2.0%	$2.4M
APOGApogee Enterprises Inc Com	0.6%	0.5%	50,000	+0.0%	$2.3M
EDAPEdap Tms S A	0.6%	0.5%	438,652	+0.0%	$2.3M
SIRISirius Xm Hldgs Inc	0.4%	0.4%	55,784	+0.0%	$1.6M
VGVenture Global Inc	0.3%	0.5%	100,000	+0.0%	$1.1M
ASHAshland	0.3%	0.2%	15,000	+0.0%	$988K
VTRSViatris Inc	0.2%	0.2%	57,696	-1.0%	$916K
MNKDMannkind Corp	0.2%	0.1%	195,073	+0.0%	$831K
BHCBausch Health	0.2%	0.2%	124,000	+0.0%	$611K
MASS908 Devices Inc	0.2%	0.1%	68,286	+0.0%	$594K
WECWec Energy Group Inc	0.1%	0.1%	3,945	+0.0%	$461K
CRBUCaribou Biosciences Inc	0.1%	0.1%	250,000	+0.0%	$440K

What Bruce & Co., Inc. bought and sold in Q2 2026, against Q1 2026.

New positions

No new positions among the largest holdings.

Added to

SUPN Supernus Pharmaceuticals+50.0% shares
FATE Fate Therapeutics Inc+25.3% shares
BBNX Beta Bionics Inc+20.9% shares

Reduced

VICR Vicor Corp-26.2% shares
UHALB U Haul Holding Company-7.7% shares
AAPL Apple Inc-5.1% shares

Sold out

Nothing sold out.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year: +21.3% /yr; S&P 500 +20.1%
3 years: +13.9% /yr; S&P 500 +20.4%
5 years: +4.3% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$369.5M	41
Q1 2026	$349.7M	41
Q4 2025	$322.5M	39
Q3 2025	$322.9M	39
Q2 2025	$307.8M	40
Q1 2025	$310.5M	41
Q4 2024	$309.9M	39
Q3 2024	$342.1M	39
Q2 2024	$299.2M	38
Q1 2024	$297.1M	37
Q4 2023	$282.2M	35
Q3 2023	$279.0M	35

Questions about Bruce & Co., Inc.'s portfolio

What stocks does Bruce & Co., Inc. own?

Bruce & Co., Inc.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 41 positions worth $369.5M. The largest are Abbvie Inc (ABBV) at 8.2%, Allstate Corp (ALL) at 7.9%, Aercap Holdings NV (AER) at 7.3%, Nextera Energy (NEE) at 7.0% and Merck Co (MRK) at 6.6%.

What did Bruce & Co., Inc. buy last quarter?

In Q2 2026, Bruce & Co., Inc. added Supernus Pharmaceuticals (SUPN) (+50.0% shares), Fate Therapeutics Inc (FATE) (+25.3% shares) and Beta Bionics Inc (BBNX) (+20.9% shares), compared with its Q1 2026 filing.

What did Bruce & Co., Inc. sell last quarter?

In Q2 2026, Bruce & Co., Inc. Vicor Corp (VICR) (-26.2% shares), U Haul Holding Company (UHALB) (-7.7% shares) and Apple Inc (AAPL) (-5.1% shares), compared with its Q1 2026 filing.

How has Bruce & Co., Inc.'s portfolio performed?

A portfolio copying Bruce & Co., Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +13.9% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +21.3% against +20.1%. Over 5 years: +4.3% a year against +11.6%.

When is Bruce & Co., Inc.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Bruce & Co., Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Bruce & Co., Inc. manage?

Bruce & Co., Inc. reported $379.5M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $369.5M.